BioSpace News Archive

Havn Life will export naturally derived psilocybin to the United States for use in IND-enabling studies and future clinical trials under FDA guidelines

Immunomic Therapeutics’ CEO to Present at the 5 th International Virtual Conference on Cancer Research & Development 2020

Renew Biopharma, a leader in drug discovery and development of novel cannabinoids for human therapeutics, announced the addition of Steve Orndorff, Ph.D., as Chief Operating Officer.

Jaguar Health, Inc. (NASDAQ:JAGX), a commercial stage pharmaceuticals company focused on discovering, developing, and commercializing novel, plant-based, non-opioid, and sustainably derived prescription medicines, issued a reminder that it is holding its first “Diarrhea Dialogues” virtual event today, October 20th, from 3:00 PM to 4:30 PM ET.

Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics announced today its partner Ono Pharmaceutical Co., Ltd. (“Ono”), a pharmaceutical company committed to creating innovative medicines, has begun a Phase 1 study in Japan for patients with pancreatic cancer. The multicenter, open-label study is evaluating the efficacy and safety of Rafael’s lead compound, CPI-613®️

The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and Citranvi Biosciences, a company led by former vaccine developers and scientists from top pharmaceutical companies, have signed an exclusive licensing agreement to develop vaccine technologies to prevent Cytomegalovirus and Epstein-Barr Virus infections.

The Stanford University School of Medicine today announced the launch of the Community Alliance to Test Coronavirus at Home (CATCH) Study, an effort that seeks to estimate the true population prevalence of COVID-19 across the 8.5 million population of the greater San Francisco Bay Area, and ultimately aid in the effort to reopen schools, workplaces and communities.

The JV InvenTeams Green Chemistry Activity Guide encourages students to use green chemistry principles to invent bioplastics.

ZOLL ® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, and CAIRE, Inc., a leading oxygen supply manufacturer, today announced the signing of an exclusive distributor agreement. As part of this agreement, ZOLL has exclusive rights to distribute the SAROS® 4000 Portable Oxygen Concentrator in all markets outside the U.S. in combination with ZOLL’s EMV+® vent

GE Healthcare today announced the availability of Serena Bright™ in the United States. Serena Bright™ is the industry’s first contrast-enhanced guided biopsy solution and will help empower clinicians and patients in their fight against breast cancer.